Page 267 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology The genetics of chronic stress in cervical lesions

35. Wang L, Li J, Wang R, et al. NGF signaling interacts with the hypertension and breast cancer: Antihypertensive drugs
Hippo/YAP pathway to regulate cervical cancer progression. as an effective adjunctive in breast cancer therapy. Cancer
Front Oncol. 2021;11:688794. Manag Res. 2022;14:1323-1329.
doi: 10.3389/fonc.2021.688794 doi: 10.2147/CMAR.S350854
36. Yuan Y, Ye HQ, Ren QC. Proliferative role of BDNF/TrkB 47. Liggett SB. The pharmacogenetics of beta2-adrenergic
signaling is associated with anoikis resistance in cervical receptors: Relevance to asthma. J Allergy Clin Immunol.
cancer. Oncol Rep. 2018;40(2):621-634. 2000;105(2):S487-S492.
doi: 10.3892/or.2018.6515 doi: 10.1016/s0091-6749(00)90048-4
37. Aziz AUR, Zhang J, Zhang C, Yu X, Wang D. The mutual 48. Green SA, Liggett SB. A proline-rich region of the
interplay between NTRK fusion genes and human third intracellular loop imparts phenotypic β1- versus
papillomavirus infection in cervical cancer progression. Mol β2-adrenergic receptor coupling and sequestration. J Biol
Clin Oncol. 2024;21(4):67. Chem. 1994;269(42):26215-26219.
doi: 10.3892/mco.2024.2765 doi: 10.1016/s0021-9258(18)47181-5
38. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved 49. Bierut LJ, Stitzel JA, Wang JC, et al. Variants in nicotinic
amplification of genital human papillomaviruses. J Clin receptors and risk for nicotine dependence. Am J Psychiatry.
Microbiol. 2000;38(1):357-361. 2008;165(9):1163-1171.
doi: 10.1128/JCM.38.1.357-361.2000 doi: 10.1176/appi.ajp.2008.07111711
39. Moreno-Smith M, Lutgendorf SK, Sood AK. Impact of stress 50. Carhart-Harris RL, Nutt DJ. Serotonin and brain function:
on cancer metastasis. Futur Oncol. 2010;6(12):1863-1881. A tale of two receptors. J Psychopharmacol. 2017;31(9):
1091-1120.
doi: 10.2217/fon.10.142
doi: 10.1177/0269881117725915
40. Iftikhar A, Islam M, Shepherd S, Jones S, Ellis I. Cancer and
stress: Does it make a difference to the patient when these 51. Siwiec M, Hess G. The use of serotonin type 7 receptor
two challenges collide? Cancers (Basel). 2021;13(2):1-29. antagonists as a pharmacological intervention in chronic
stress. Insights from animal studies. Int J Biochem Cell Biol.
doi: 10.3390/cancers13020163
2024;175:106647.
41. Chen G, Qiu L, Gao J, et al. Stress hormones: Emerging doi: 10.1016/j.biocel.2024.106647
targets in gynecological cancers. Front Cell Dev Biol.
2021;9:699487. 52. Bauer MB, Currie KPM. Serotonin and the serotonin
transporter in the adrenal gland. Vitam Horm. 2024;124:
doi: 10.3389/fcell.2021.699487
39-78.
42. Lai LP, Mitchell J. β2-adrenergic receptors expressed on
murine chondrocytes stimulate cellular growth and inhibit doi: 10.1016/bs.vh.2023.06.002
the expression of Indian hedgehog and collagen type XJ. Cell 53. Tjurmina OA, Armando I, Saavedra JM, Goldstein DS,
Biochem. 2008;104(2):545-553. Murphy DL. Exaggerated adrenomedullary response
to immobilization in mice with targeted disruption
doi: 10.1002/jcb.21646
of the serotonin transporter gene. Endocrinology.
43. Pullar CE, Isseroff RR. The beta 2-adrenergic receptor 2002;143(12):4520-4526.
activates pro-migratory and pro-proliferative pathways doi: 10.1210/en.2002-220416
in dermal fibroblasts via divergent mechanisms. J Cell Sci.
2006;119(3):592-602. 54. Murphy DL, Lesch KP. Targeting the murine serotonin
transporter: Insights into human neurobiology. Nat Rev
doi: 10.1242/jcs.02772
Neurosci. 2008;9(2):85-96.
44. Floras JS. Epinephrine and the genesis of hypertension. doi: 10.1038/nrn2284
Hypertension. 1992;19(1):1-18.
55. Brindley RL, Bauer MB, Blakely RD, Currie KPM. An
doi: 10.1161/01.hyp.19.1.1
interplay between the serotonin transporter (SERT) and
45. Carlos-Escalante JA, de Jesús-Sánchez M, Rivas-Castro A, 5-HT receptors controls stimulus-secretion coupling in
Pichardo-Rojas PS, Arce C, Wegman-Ostrosky T. The use sympathoadrenal chromaffin cells. Neuropharmacology.
of antihypertensive drugs as coadjuvant therapy in cancer. 2016;110:438-448.
Front Oncol. 2021;11:660943.
doi: 10.1016/j.neuropharm.2016.08.015
doi: 10.3389/fonc.2021.660943
56. Brindley RL, Bauer MB, Blakely RD, Currie KPM. Serotonin
46. Fan Y, Khan NH, Farhan Ali Khan M, et al. Association of and serotonin transporters in the adrenal medulla: A

Volume 9 Issue 2 (2025) 259 doi: 10.36922/EJMO025100047